SecBot SecBot
SC 13G/A ·Filed Oct 7, 2026

TXG

10x Genomics, Inc.
NEUTRAL
Impact 2/10
Horizonweeks Processed18d 16h ago SEC0001104659-26-114392
Passive stake amendment
Actionable Insight • Neutral

Monitor for any future conversion to a 13D filing, which would signal activist intent. For now, ARK remains a passive holder with a stable position.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+5d
TXG ▼ -6.33% at T+5d
NEUTRAL call -6.33% · α vs SPY -6.05% · entry $77.28 → $72.39
Next anchor: T+20d in 9d
Latest observation: T+11 -17.30% FF3 residual α
Entry = T+0 close
Oct 7, 2026
via day close
T+1d
+4.36%
call +4.36% · α +3.76%
$80.65
settled 18d ago
T+5d
-6.33%
call -6.33% · α -6.05%
$72.39
settled 12d ago
T+20d
Pending
in 9d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

ARK Investment Management LLC and Catherine D. Wood filed Amendment No. 4 to their Schedule 13G, reporting a 5.22% passive stake in 10x Genomics as of September 30, 2026. The filing shows a slight reduction from the prior 13G/A filed in August 2026, where the stake was reported at 5.22% as well, but the share count decreased from 6,272,998 to 6,272,998 (no change in percentage, but the prior filing's share count was the same; the stake appears stable). This is a routine passive update with no material change in position.

Key Financial Metrics

Stake
5.22%
Investor
ARK Investment Management LLC

Key Facts

  • ARK Investment Management and Catherine Wood filed Amendment No. 4 to Schedule 13G for 10x Genomics
  • Beneficial ownership reported at 6,272,998 shares of Class A Common Stock, representing 5.22% of shares outstanding
  • Filing date: October 7, 2026; event date: September 30, 2026
  • ARK disclaims beneficial ownership of shares held by Catherine Wood, and vice versa
  • Filer certifies passive intent under Rule 13d-1(b) — no activist intent

Financial Impact

No material financial impact — stake unchanged at 5.22%

Risk Factors

  • Potential for ARK to reduce stake further if fund flows or strategy shift
  • No change in position — no catalyst for near-term price movement

Investment Themes

Genomics & Gene Editing

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001104659-26-114392
Document: 0001104659-26-114392-index-headers.html0001104659-26-114392
Document: 0001104659-26-114392-index.html0001104659-26-114392
Document: 0001104659-26-114392.txt0001104659-26-114392
22 reports for TXG
Performance horizon
14% Hit rate @ T+1 1 of 7 directional calls Went positive at some point 1 of 7 best @ T+1▲ +0.90%Sep 3, 2026
Filters
Rows
Reports for TXG — sortable, filterable
TypeNow
Oct 23, 2026
2d ago
Institutional Cluster
NEUTRAL ★ 2/10
$71.20awaiting T+1—$71.29 (+0.13%)
Oct 7, 2026
18d ago
SC 13G/A
NEUTRAL ★ 2/10
$77.28 $80.65▲ +4.36%▲ +3.76%$71.29 (−7.75%)
Sep 24, 2026
4w ago
Insider Cluster
NEUTRAL ★ 3/10
$85.71 $88.50▲ +3.26%▲ +4.00%$71.29 (−16.82%)
Sep 22, 2026
4w ago
144
NEUTRAL ★ 2/10
$75.62 $84.11▲ +11.23%▲ +11.31%$71.29 (−5.73%)
Sep 11, 2026
6w ago
Insider Cluster
NEUTRAL ★ 3/10
$70.11 $74.39▲ +6.10%▲ +6.56%$71.29 (+1.68%)
Sep 3, 2026
7w ago
144
BEARISH ★ 4/10
$63.22 $62.65▲ +0.90%▲ +0.52%$71.29 (−12.76%)
Aug 28, 2026
8w ago
Insider Cluster
NEUTRAL ★ 4/10
$62.45 $59.98▼ −3.96%▼ −3.27%$71.29 (+14.16%)
Aug 26, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$64.85 $61.54▼ −5.10%▼ −4.88%$71.29 (+9.93%)
Aug 19, 2026
9w ago
Institutional Cluster
MIXED ★ 5/10
$63.87 $65.12▲ +1.96%▲ +1.55%$71.29 (+11.62%)
Aug 19, 2026
9w ago
Court Ruling
BEARISH ★ 7/10
$63.87 $65.12▼ −1.97%▼ −1.56%$71.29 (−11.63%)
Showing 10 of 22

US Market Status

Market Open — Closes in 6h 13m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 7, 2026